TAIWAN ADVANCE BIO-PHARM INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 4186 for the last semiannual is 151.67 M TWD, and it's 18.96% lower compared to the previous semiannual. The net income of H1 24 is -4.41 M TWD.